跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PERSERIS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PERSERIS
Authorized
STANDARD
PERSERIS
海倫司國際控股有限公司
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
07e2af83ac741945
Company
海倫司國際控股有限公司
Type
Standard
Approval Details
Approval Id
07e2af83ac741945
Drug Approval Canada Name
PERSERIS
Product Name
PERSERIS
Status
Cancelled Post Market
Status Date
2024-07-26
Original Market Date
2021-06-15
Din
02507838
Drug Class
Human
Dosage Form
Kit , Powder For Suspension, Sustained-Release
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
28:16.08.04
Atc Original
N05AX08 RISPERIDONE
Atc Name
n 05 ax 08
Aig Number
0124332013
Company Name
海倫司國際控股有限公司
Company Address
10 Carlson Court, Suite 701, Etobicoke, Ontario, Canada, M9W 6L2
Active Ingredients
RISPERIDONE
90 MG / SYR
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
07e2af83ac741945
Type
Standard
Back to Health Canada Approvals